Empirical antibiotics for recurrent urinary tract infections in children

논문상세정보
    • 저자 오지은 최현길 이지영
    • 제어번호 105967642
    • 학술지명 고신대학교 의과대학 학술지
    • 권호사항 Vol. 33 No. 2 [ 2018 ]
    • 발행처 고신대학교(의대) 고신대학교 의과대학 학술지
    • 자료유형 학술저널
    • 수록면 159-170
    • 언어 English
    • 출판년도 2018
    • 등재정보 KCI등재
    • 판매처
    유사주제 논문( 0)

' Empirical antibiotics for recurrent urinary tract infections in children' 의 참고문헌

  • Urinary tract infection : clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months
    Roberts KB [2011]
  • Ultrasound grading of hydronephrosis : Introduction to the system used by the society for fetal urology
    Fernbach SK [1993]
  • The epidemiology and clinical presentation of urinary tract infections in children younger than 2 years of age
    Roberts KB [1999]
  • The Efficacy of Tc99m dimercaptosuccinic acid(Tc-DMSA)scintigraphy and ultrasonography in detecting renal scars in children with primary vesicoureteral reflux(VUR)
    Temiz Y [2006]
  • The Antibiotic Resistance Pattern of Gram-Negative Bacteria in Children Younger Than 24 Months with a Urinary Tract Infection: A Retrospective Single-Center Study over 15 Consecutive Years
  • Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials
    Conway PH [2007]
  • Recurrence and follow-up after urinary tract infection under the age of 1 year
    Nuutinen M [2001]
  • Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children
  • Nelson textbook of pediatrics
    Elder JS [2015]
  • Is screening for vesicoureteral reflux mandatory in infants with antenatal renal pelvis dilatation?
    Lidefelt KJ [2006]
  • International system of radiographic grading of vesicoureteric reflux
    Lebowitz RL [1985]
  • Extended-spectrum β-lactamase-producing bacteria causing community-acquired urinary tract infections in children
    Megged O [2014]
  • Extended-Spectrum Beta-Lactamases–Red Española de Investigación en Patología Infecciosa/Grupo de Estudio de Infección Hospitalaria Group. β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts
  • Epidemiology of urinary tract infections : incidence, morbidity, and economic costs
    Foxman B [2002]
  • Clinical relevance and implications of antenatal hydronephrosis
    Dudley JA [1997]
  • Clinical correlation of the CLSI susceptibility breakpoint for piperacillin-tazobactam against extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella species
    Gavin PJ [2006]
  • Can we really use β-lactam/β-lactam inhibitor combinations for the treatment of infections caused by extended-spectrum β-lactamase-producing bacteria?
    Perez F [2012]
  • Antibiotic resistance patterns of outpatient pediatric urinary tract infections
    Edlin RS [2013]
  • Antibiotic policy and prescribing strategies for therapy of extended-spectrum β-lactamase-producing Enterobacteriaceae : the role of piperacillin–tazobactam
    Peterson LR [2008]